Clinical Trial Update: A Study of the PK, Safety and Antiviral Activity of A-831 in HCV Carriers [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update indicates that the Phase 1/2 study of A-831 in chronic hepatitis C carriers has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• A-831

Snippet

Sponsor: Arrow Therapeutics | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: TERMINATED